Columbus Circle Investors’s Cytokinetics CYTK Stock Holding History

Columbus Circle Investors’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-32,808	Closed	-$312K	–	279
2014 Q1	$312K	Sell	32,808 -107,259	-77%	-$970K	﹤0.01%	279
2013 Q4	$910K	Sell	140,067 -51,255	-27%	-$337K	0.01%	269
2013 Q3	$1.45M	Buy	191,322 +40,314	+27%	+$432K	0.01%	274
2013 Q2	$1.75M	Buy	+151,008	New	+$1.19M	0.01%	254

Other funds holding CYTK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LPU

Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

IIM

Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Columbus Circle Investors's CYTK Position: Q2 2014 in Review

Columbus Circle Investors sold out of Cytokinetics (CYTK) in Q2 2014, closing a stake of 32,808 shares — an estimated $312K sold.

Columbus Circle Investors first reported a position in CYTK in Q2 2013 and held it in 4 quarters. The position peaked at $1.75M in Q2 2013. 89 funds tracked by Wall St. Rank hold CYTK as of Q2 2014.

Columbus Circle Investors reported no remaining Cytokinetics position as of Q2 2014 after selling out during the quarter.
Columbus Circle Investors sold 32,808 Cytokinetics shares in Q2 2014, an estimated $312K.
Columbus Circle Investors first reported a position in Cytokinetics in Q2 2013 and held it in 4 quarters.
Columbus Circle Investors's Cytokinetics position peaked at $1.75M in Q2 2013.
89 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2014.

Based on Columbus Circle Investors's 13F filing for Q2 2014, filed 31 Jul 2014.